calpain-inhibitor-iii and Ischemia

calpain-inhibitor-iii has been researched along with Ischemia* in 1 studies

Other Studies

1 other study(ies) available for calpain-inhibitor-iii and Ischemia

ArticleYear
Ischemia promotes calpain-mediated degradation of p120-catenin in SH-SY5Y cells.
    Biochemical and biophysical research communications, 2007, Feb-16, Volume: 353, Issue:3

    p120-catenin contributes to the cadherin-mediated adhesion and aggregation of cells. mu-Calpain was activated and p120-catenin was degraded after 36 h of ischemia in differentiated SH-SY5Y cells. Calpain inhibitors Cbz-Val-Phe-H (MDL28170, 20 microM) and N-acetyl-leucyl-leucyl-norleucinal (ALLN, 20 microM) increased the levels of dephosphorylated p120-catenin, aggregation, and cell survival as detected by reduced LDH release in ischemic cells. However, a proteasome inhibitor lactacystin had no such effects. This is the first report of the calpain-mediated degradation of p120-catenin and an association between the level of dephosphorylated p120-catenin and cell aggregation in ischemic neuronal cells.

    Topics: Acetylcysteine; Calpain; Catenins; Cell Adhesion Molecules; Cell Aggregation; Cell Death; Cell Line, Tumor; Delta Catenin; Dipeptides; Humans; Ischemia; Leupeptins; Neuroblastoma; Phosphoproteins

2007